A. Dietz

发表

Cyclooxygenase‐independent inhibition of dendritic cell maturation by aspirin

R. Matasić, S. Vuk-Pavlović, A. Dietz, 2000, Immunology.

High efficiency adenovirus-mediated gene transfer to human dendritic cells.

A. Dietz, S. Vuk-Pavlović, A. Dietz, 1998, Blood.

Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML.

P. Bulur, S. Vuk-Pavlović, A. Tefferi, 2006, Cytotherapy.

Maturation of human dendritic cells as sulfasalazine target.

R. Matasić, S. Vuk-Pavlović, A. Dietz, 2001, Croatian medical journal.

In vivo sodium iodide symporter gene therapy of prostate cancer

D. Tindall, A. Dietz, C. Spitzweg, 2001, Gene Therapy.

Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells.

P. Bulur, S. Vuk-Pavlović, A. Tefferi, 2000, Journal of hematotherapy & stem cell research.

Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells.

P. Bulur, S. Vuk-Pavlović, M. Litzow, 2001, Cytotherapy.

Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanoma.

S. Vuk-Pavlović, D. Gastineau, G. Butler, 2004, Cytotherapy.

Mature myeloid dendritic cells for clinical use prepared from CD14+ cells isolated by immunomagnetic adsorption.

S. Vuk-Pavlović, D. Gastineau, D. Padley, 2001, Journal of hematotherapy & stem cell research.

Maturation of dendritic cells infected by recombinant adenovirus can be delayed without impact on transgene expression

P. Bulur, S. Vuk-Pavlović, V. Pankratz, 2001, Gene Therapy.

Infrastructure Development for Human Cell Therapy Translation

D. Gastineau, A B Dietz, D A Gastineau, 2007, Clinical pharmacology and therapeutics.

Osteogenic Differentiation of Mesenchymal Stromal Cells: A Comparative Analysis Between Human Subcutaneous Adipose Tissue and Dental Pulp.

J. Smith, P. Di Iorio, I. D'alimonte, 2017, Stem cells and development.